Sparian Biosciences
Gus Northrop has a diverse work experience in the biotechnology and pharmaceutical industry. Gus is currently serving as the Director of Corporate Strategy at Sparian Biosciences since January 2023. Prior to this role, Gus worked as a Program Director at Sparian Biosciences from October 2021 to January 2023.
Before joining Sparian Biosciences, Gus was a Senior Specialist at Merck, where they worked on the KEYTRUDA project from June 2020 to March 2021.
Gus also has educational experience from Columbia Business School, where they pursued an MBA from August 2017 to May 2020. During this time, they gained practical experience as an intern at BioMarin Pharmaceutical Inc. in June 2018, working on the ROCTAVIAN project.
Gus began their career at Globe Life Sciences Limited in 2012. Gus held various roles there, including Consultant, Senior Analyst, Business Analyst, and Research Analyst, from May 2017 to May 2017, November 2014 to May 2017, January 2013 to November 2014, and March 2012 to January 2013, respectively.
Gus started their professional journey as an Analyst Intern at IQVIA in November 2011 and served until February 2012.
Gus Northrop has an education history that consists of obtaining an MBA degree from Columbia Business School. Additionally, they earned a BA in Medical Science from the University of Oxford. The specific start and end years for each degree are not provided.
This person is not in any teams
Sparian Biosciences
Sparian Biosciences is an early-stage CNS-focused biopharmaceutical company committed to developing novel, transformational therapies. Diseases of the central nervous system represent a major unmet need but recently there has been little innovation and development. Sparian was co-founded by Gavril Pasternak, MD PhD and Jeff Reich, MD to develop therapeutics targeting the brain through innovative science and novel drug discovery. Currently, we have 4 programs addressing various aspects of the opioid crisis - a crisis in urgent need of innovation. Two of our compounds come from the Pasternak Lab at Memorial Sloan Kettering Cancer Center, one comes from the USC Michelson Center for Convergent Bioscience and one comes from a collaboration with Washington University. Core to our strategy, we have ongoing scientific and clinical collaborations with MSKCC, Washington University, St. Louis College of Pharmacy, Rutgers University Medical School, University of Florida, and the U.S. Department of Defense. Sparian is based out of BioLabs@NYULangone in NYC, a national biotech incubator, and is a member of the StartupNY program.